CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Pfizer Inc - PFE CFD

43.55
0.46%
0.05
Low: 43.32
High: 44.02
Market Trading Hours* (UTC) Opens on Wednesday at 09:10

Mon: 09:10 - 00:00

Tue - Thu: 00:00 - 01:00 09:10 - 00:00

Fri: 00:00 - 01:00 09:10 - 22:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.05
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.006402 %
Charges from borrowed part ($-0.26)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.006402%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.005927 %
Charges from borrowed part ($-0.24)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.005927%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Pfizer Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 43.75
Open* 43.75
1-Year Change* -18.3%
Day's Range* 43.32 - 44.02
52 wk Range 41.45-56.32
Average Volume (10 days) 27.76M
Average Volume (3 months) 448.45M
Market Cap 245.64B
P/E Ratio 7.99
Shares Outstanding 5.61B
Revenue 100.33B
EPS 5.47
Dividend (Yield %) 3.74771
Beta 0.61
Next Earnings Date May 1, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 8, 2023 43.55 0.00 0.00% 43.55 43.55 43.55
Feb 7, 2023 43.52 -0.40 -0.91% 43.92 44.03 43.23
Feb 6, 2023 43.75 -0.13 -0.30% 43.88 44.28 43.56
Feb 3, 2023 44.02 -0.25 -0.56% 44.27 44.40 43.83
Feb 2, 2023 44.26 0.25 0.57% 44.01 44.44 43.47
Feb 1, 2023 44.01 -0.20 -0.45% 44.21 44.24 43.39
Jan 31, 2023 44.21 0.72 1.66% 43.49 44.25 41.79
Jan 30, 2023 43.49 -0.11 -0.25% 43.60 44.11 43.29
Jan 27, 2023 43.71 -0.43 -0.97% 44.14 44.32 43.45
Jan 26, 2023 44.14 -1.00 -2.22% 45.14 45.19 43.60
Jan 25, 2023 45.01 0.31 0.69% 44.70 45.15 44.49
Jan 24, 2023 44.71 -0.26 -0.58% 44.97 45.01 43.99
Jan 23, 2023 44.97 -0.11 -0.24% 45.08 45.29 44.57
Jan 20, 2023 44.99 0.00 0.00% 44.99 45.41 44.70
Jan 19, 2023 44.98 0.00 0.00% 44.98 45.24 44.52
Jan 18, 2023 45.04 -1.00 -2.17% 46.04 46.28 44.92
Jan 17, 2023 46.04 -1.07 -2.27% 47.11 47.29 45.70
Jan 13, 2023 47.72 0.10 0.21% 47.62 48.13 46.99
Jan 12, 2023 47.62 0.26 0.55% 47.36 47.71 46.56
Jan 11, 2023 47.36 -0.28 -0.59% 47.64 47.80 46.81

Pfizer Inc Events

Time (UTC) Country Event
Friday, April 28, 2023

Time (UTC)

13:00

Country

US

Event

Pfizer Inc Annual Shareholders Meeting
Pfizer Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Monday, May 1, 2023

Time (UTC)

12:30

Country

US

Event

Q1 2023 Pfizer Inc Earnings Release
Q1 2023 Pfizer Inc Earnings Release

Forecast

-

Previous

-
Thursday, May 18, 2023

Time (UTC)

10:59

Country

IN

Event

Q4 2023 Pfizer Ltd Earnings Release
Q4 2023 Pfizer Ltd Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 52824 52546 40825 41172 41651 81288
Revenue 52824 52546 40825 41172 41651 81288
Cost of Revenue, Total 11925 10838 8872 8043 8405 30688
Gross Profit 40899 41708 31953 33129 33246 50600
Total Operating Expense 43820 39557 36763 28841 33839 57636
Selling/General/Admin. Expenses, Total 14837 14784 12419 12485 11402 12256
Research & Development 7872 7657 7713 7731 9340 11582
Depreciation / Amortization 4056 4758 4736 4462 3348 3700
Unusual Expense (Income) 6058 2594 4675 -2914 2619 3897
Other Operating Expenses, Total -928 -1074 -1652 -966 -1275 -4487
Operating Income 9004 12989 4062 12331 7812 23652
Interest Income (Expense), Net Non-Operating -824 -972 -538 -877 -538 560
Gain (Loss) on Sale of Assets 171 288 71 32 -237 99
Net Income Before Taxes 8351 12305 3594 11485 7036 24311
Net Income After Taxes 7228 11954 3264 10545 6666 22459
Minority Interest -31 -47 -36 -29 -36 -45
Net Income Before Extra. Items 7197 11907 3228 10516 6630 22414
Total Extraordinary Items 17 9402 7924 5757 2529 -434
Net Income 7214 21309 11152 16273 9159 21980
Total Adjustments to Net Income 0 -2 0 -1 0 -1
Income Available to Common Excl. Extra. Items 7197 11905 3228 10515 6630 22413
Income Available to Common Incl. Extra. Items 7214 21307 11152 16272 9159 21979
Diluted Net Income 7214 21307 11152 16272 9159 21979
Diluted Weighted Average Shares 6159 6058 5977 5675 5632 5708
Diluted EPS Excluding Extraordinary Items 1.16853 1.96517 0.54007 1.85286 1.1772 3.92659
Dividends per Share - Common Stock Primary Issue 1.2 1.28 1.36 1.44 1.52 1.56
Diluted Normalized EPS 2.10748 2.31727 1.04885 1.22837 1.45366 4.09303
Other, Net -1 -1 -1
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 14516 18977 24094 23635 25661
Revenue 14516 18977 24094 23635 25661
Cost of Revenue, Total 4187 6986 9925 9611 10010
Gross Profit 10329 11991 14169 14024 15651
Total Operating Expense 8989 13063 16447 19059 15788
Selling/General/Admin. Expenses, Total 2901 2794 2733 4069 2691
Research & Development 2010 2270 2738 4565 2655
Depreciation / Amortization 858 931 981 916 835
Unusual Expense (Income) -25 754 1613 1283 122
Other Operating Expenses, Total -942 -672 -1543 -1385 -525
Operating Income 5527 5914 7647 4576 9873
Interest Income (Expense), Net Non-Operating 127 637 190 -394 -823
Gain (Loss) on Sale of Assets 39 58 1 0 1
Other, Net -1 -2 1 -1
Net Income Before Taxes 5692 6609 7836 4183 9050
Net Income After Taxes 4884 5566 8167 3849 7878
Minority Interest -9 -26 -12 2 -6
Net Income Before Extra. Items 4875 5540 8155 3851 7872
Total Extraordinary Items 1 24 -9 -458 -9
Net Income 4876 5564 8146 3393 7863
Total Adjustments to Net Income 1 -1 1
Income Available to Common Excl. Extra. Items 4876 5539 8155 3851 7873
Income Available to Common Incl. Extra. Items 4877 5563 8146 3393 7864
Diluted Net Income 4877 5563 8146 3393 7864
Diluted Weighted Average Shares 5662 5678 5725 5768 5758
Diluted EPS Excluding Extraordinary Items 0.86118 0.97552 1.42445 0.66765 1.36732
Dividends per Share - Common Stock Primary Issue 0.39 0.39 0.39 0.39 0.4
Diluted Normalized EPS 0.82179 1.06851 1.40629 0.74896 1.31052
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 38949 41141 49926 32803 35067 59693
Cash and Short Term Investments 17850 19992 18833 9646 12221 31069
Cash & Equivalents 2595 1342 1139 1121 1784 1944
Short Term Investments 15255 18650 17694 8525 10437 29125
Total Receivables, Net 8225 8221 8025 6772 7930 11479
Accounts Receivable - Trade, Net 8225 8221 8025 6772 7930 11479
Total Inventory 6783 7578 7508 7068 8046 9059
Other Current Assets, Total 6091 5350 15560 9317 6870 8086
Total Assets 171615 171797 159422 167594 154229 181476
Property/Plant/Equipment, Total - Net 13318 13865 13385 14258 15293 17721
Property/Plant/Equipment, Total - Gross 28125 30037 29977 29248 30104 32794
Accumulated Depreciation, Total -14807 -16172 -16591 -14990 -14812 -15074
Goodwill, Net 54449 55952 53411 48202 49577 49208
Intangibles, Net 52648 48741 35211 33936 28471 25146
Long Term Investments 7116 7015 2767 20147 20262 21526
Other Long Term Assets, Total 5135 5083 4722 18248 5559 8182
Total Current Liabilities 31115 30427 31858 37304 25920 42671
Accounts Payable 4536 4656 4674 3887 4309 5578
Accrued Expenses 2487 2196 2397 2659 3379 3781
Notes Payable/Short Term Debt 6463 6407 4055 14733 701 605
Current Port. of LT Debt/Capital Leases 4225 3546 4776 1462 2002 1636
Other Current Liabilities, Total 13404 13622 15956 14563 15529 31071
Total Liabilities 112071 100489 96015 104450 90991 104276
Total Long Term Debt 31398 33538 32909 35955 37133 36195
Long Term Debt 31398 33538 32909 35955 37133 36195
Deferred Income Tax 30753 3900 3700 5652 4063 349
Minority Interest 296 348 351 303 235 262
Other Liabilities, Total 18509 32276 27197 25236 23640 24799
Total Equity 59544 71308 63407 63144 63238 77200
Preferred Stock - Non Redeemable, Net 24 21 19 17 0
Common Stock 461 464 467 468 470 473
Additional Paid-In Capital 82685 84278 86253 87428 88674 90591
Retained Earnings (Accumulated Deficit) 71774 85291 89554 97670 96770 103394
Treasury Stock - Common -84364 -89425 -101610 -110801 -110988 -111361
Unrealized Gain (Loss) -131 401 -68 -35 116 -220
Other Equity, Total -10905 -9722 -11208 -11603 -11804 -5677
Total Liabilities & Shareholders’ Equity 171615 171797 159422 167594 154229 181476
Total Common Shares Outstanding 6070 5979 5717 5534 5567 5620
Total Preferred Shares Outstanding 0.0006 0.00052 0.00048 0.00043 0 0
Apr 2021 Jul 2021 Oct 2021 Dec 2021 Apr 2022
Total Current Assets 39533 48814 57900 59693 54420
Cash and Short Term Investments 13667 21700 29696 31069 23897
Cash & Equivalents 1768 2372 1966 1944 2470
Short Term Investments 11899 19328 27730 29125 21427
Total Receivables, Net 9864 10587 11897 11479 13225
Accounts Receivable - Trade, Net 9864 10587 11897 11479 13225
Total Inventory 8493 8948 8640 9059 9979
Other Current Assets, Total 7509 7579 7667 8086 7319
Total Assets 158818 169920 179188 181476 183841
Property/Plant/Equipment, Total - Net 14011 14224 14436 14882 15109
Property/Plant/Equipment, Total - Gross 29116 29552 29839 29955 30467
Accumulated Depreciation, Total -15105 -15328 -15403 -15074 -15358
Goodwill, Net 49791 49867 49489 49208 50211
Intangibles, Net 27974 27323 26306 25146 29816
Long Term Investments 20228 20942 21597 21526 20737
Other Long Term Assets, Total 7281 8750 9460 11021 13548
Total Current Liabilities 26652 35664 41803 42671 39268
Accounts Payable 4064 4327 4698 5578 5506
Accrued Expenses 1985 2015 2571 3332 2249
Notes Payable/Short Term Debt 676 201 966 605 385
Current Port. of LT Debt/Capital Leases 3676 3687 2663 1636 260
Other Current Liabilities, Total 16251 25434 30905 31520 30868
Total Liabilities 90198 99878 103496 104276 101417
Total Long Term Debt 35347 35354 36250 36195 35656
Long Term Debt 35347 35354 36250 36195 35656
Deferred Income Tax 4355 4161 328 349 655
Minority Interest 245 273 275 262 261
Other Liabilities, Total 23599 24426 24840 24799 25577
Total Equity 68620 70042 75692 77200 82424
Common Stock 472 472 473 473 476
Additional Paid-In Capital 89002 89336 89973 90591 90844
Retained Earnings (Accumulated Deficit) 95158 96346 102252 103394 111193
Treasury Stock - Common -111349 -111356 -111359 -111361 -113931
Unrealized Gain (Loss) -26 79 -146 -220 -133
Other Equity, Total -4637 -4835 -5501 -5677 -6025
Total Liabilities & Shareholders’ Equity 158818 169920 179188 181476 183841
Total Common Shares Outstanding 5594 5599 5611 5620 5591
Total Preferred Shares Outstanding 0
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 7246 21355 11188 16302 9652 22025
Cash From Operating Activities 16193 16802 15827 12587 14403 32580
Cash From Operating Activities 5757 6269 6384 6010 4777 5191
Deferred Taxes -700 -2410 -2205 614 -1468 -4293
Non-Cash Items 3791 -9748 1387 -6307 1717 -3147
Cash Taxes Paid 2521 2489 3655 3664 3153 7427
Cash Interest Paid 1451 1518 1311 1587 1641 1467
Changes in Working Capital 99 1336 -927 -4032 -275 12804
Cash From Investing Activities -7791 -4740 4525 -3945 -4271 -22546
Capital Expenditures -1999 -2217 -2196 -2594 -2791 -2711
Other Investing Cash Flow Items, Total -5792 -2523 6721 -1351 -1480 -19835
Cash From Financing Activities -9228 -13350 -20441 -8485 -9649 -9816
Financing Cash Flow Items -536 -612 -589 -735 11121 16
Total Cash Dividends Paid -7317 -7659 -7978 -8043 -8440 -8729
Issuance (Retirement) of Stock, Net -3981 -4138 -10939 -8471 425 0
Issuance (Retirement) of Debt, Net 2606 -941 -935 8764 -12755 -1103
Foreign Exchange Effects -215 53 -116 -32 -8 -59
Net Change in Cash -1041 -1235 -205 125 475 159
Apr 2021 Jul 2021 Oct 2021 Dec 2021 Apr 2022
Net income/Starting Line 4886 10475 18633 22025 7870
Cash From Operating Activities 4539 15836 26666 32580 6541
Cash From Operating Activities 1226 2554 3914 5191 1187
Deferred Taxes 199 -3702 -4293 -2321
Non-Cash Items -446 -1590 -2997 -3147 537
Cash Taxes Paid 394 2188 2943 7427 354
Cash Interest Paid 445 798 1205 1467 453
Changes in Working Capital -1326 4397 10818 12804 -732
Cash From Investing Activities -1747 -9884 -19960 -22546 567
Capital Expenditures -554 -1094 -1718 -2711 -643
Other Investing Cash Flow Items, Total -1193 -8790 -18242 -19835 1210
Cash From Financing Activities -2807 -5364 -6465 -9816 -6578
Financing Cash Flow Items -610 -510 -185 16 -500
Total Cash Dividends Paid -2172 -4355 -6540 -8729 -2249
Issuance (Retirement) of Debt, Net -25 -499 260 -1103 -1829
Foreign Exchange Effects 0 5 -32 -59 -1
Net Change in Cash -15 593 209 159 529
Issuance (Retirement) of Stock, Net 0 -2000
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.7471 491001204 5107541 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 5.1238 287612741 395713 2022-09-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 5.0984 286187374 1836743 2022-09-30 LOW
Capital World Investors Investment Advisor 4.4332 248850529 -1276218 2022-09-30 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 3.7567 210874152 -8297495 2022-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.9675 110442140 1859302 2022-09-30 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 1.2492 70123906 6001894 2022-09-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.0112 56763604 200794 2021-12-31 LOW
Capital International Investors Investment Advisor 0.9856 55323878 5892896 2022-09-30 LOW
State Farm Insurance Companies Insurance Company 0.9543 53568997 0 2022-09-30 LOW
BofA Global Research (US) Research Firm 0.803 45074753 -582392 2022-09-30 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.7631 42832953 -453753 2022-09-30 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.7449 41814509 -977163 2022-09-30 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 0.7363 41330356 393541 2022-09-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.7347 41242414 1009399 2022-09-30 LOW
MFS Investment Management Investment Advisor/Hedge Fund 0.7287 40906577 -874608 2022-09-30 LOW
BlackRock Asset Management Ireland Limited Investment Advisor 0.6492 36441408 1403401 2022-09-30 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.632 35478928 -2969100 2022-09-30 LOW
T. Rowe Price Associates, Inc. Investment Advisor 0.5195 29162770 -5775440 2022-09-30 LOW
Mellon Investments Corporation Investment Advisor/Hedge Fund 0.5151 28915413 -87396 2022-09-30 LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
+500000+

Traders

93000+

Active clients monthly

$57000000+

Monthly investing volume

$31000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Pfizer Company profile

Pfizer Inc. (PFE) is a New York-based multinational corporation engaged in the business of discovering, developing, producing and selling pharmaceuticals. It is one of the world's largest pharmaceutical companies and ranked 64 on the 2020 Fortune 500 list.

Pfizer shares are traded on the New York Stock Exchange under the ticker symbol PFE. The company is a constituent of the S&P 100 Index and S&P 500 Index (US500). Pfizer stock was also a constituent of the Dow Jones Industrial Average (US30) from 2004 to 2020. However, it was replaced by Amgen (AMGN) on August 31, 2020.

Get all the information you need on the PFE stock price today with Capital.com’s comprehensive chart.

The company was founded in 1849 in New York by two cousins, Charles Pfizer and Charles F Erhart. Already by 1906, Pfizer’s sales totalled $3.4m (£2.6m, €2.9m). Originally a manufacturer of fine chemicals, the business moved into pharmaceuticals in the second half of the 20th century.

Acquisitions have been one of the key growth strategies for Pfizer. Some of the firm’s major purchases include Warner-Lambert in 2000, Pharmacia in 2003, Wyeth in 2009, King Pharmaceuticals in 2010, Innopharma in 2014, and Medivation and Anacor Pharmaceuticals in 2016. In December 2018, the company announced a joint merger of its consumer healthcare division with the British pharma giant GlaxoSmithKline. The transaction closed in August 2019.

Today, Pfizer is headquartered in New York City, and its research HQ is in Groton, Connecticut. The company has research and development staff across the world to support its product pipeline. As well as numerous locations across the US, the company also has sites in Europe, India, Japan, Australia and Latin America.

Pfizer manufactures a broad range of medicines and vaccines for such therapeutic areas as immunology and inflammation, cardiovascular and metabolic diseases, oncology, neurological and psychiatric illnesses, and rare diseases. It is involved both in carrying out clinical trials and conducting research and development. Among its best-known products are the blockbuster drug Lipitor, the antibiotic Zithromax, and erectile dysfunction treatment Viagra.

In November 2020, Pfizer’s Covid-19 vaccine, developed with the German drugmaker BioNTech (BNTX), was found to be more than 90 per cent effective.

With Capital.com’s PFE chart you can not only quickly view the current Pfizer stock quote, but also trace the company’s shares value in historic terms.

In regard to the Pfizer Inc stock history, the company went public on June 22, 1942. The $5.9 million IPO was one of the largest of that year, with Pfizer offering shares at $24.75 apiece and reaching a market cap of $12.4 million on the first day of trading.

The business’ growth into one of the world's largest pharmaceutical corporations has generated hefty profits for its early investors. By 1998, when its famous Viagra medicine was launched in the US and Europe, Pfizer’s market cap had already soared by more than a million per cent from its IPO valuation.

The Pfizer Inc. share price had been on a general upward trend from the global financial crisis, when it fell as low as $12.30, up until November 2018, when it peaked at $46.30.

On March 23, 2020, the stock plunged to $27.88 per share amid the global economic uncertainty caused by the Covid-19 pandemic. The shares then quickly recovered to trade at $37-$39 throughout May, right before falling to $32 by the end of June. The Pfizer share value then inched higher to fluctuate in the $36-$39 range throughout August-October. The stock briefly broke out in early November after the company's Covid-19 vaccine, tested on 43,500 people, proved 90 per cent effective in a final-phase study.

You can go long or short on the company’s shares and trace all the latest ups and downs of the Pfizer stock price now using Capital.com’s proprietary trading platform.

Industry: Pharmaceuticals (NEC)

235 E 42nd St
NEW YORK
NEW YORK 10017
US

Income Statement

  • Annual
  • Quarterly

People also watch

US100

12,724.50 Price
+2.080% 1D Chg, %
Long position overnight fee -0.0187%
Short position overnight fee 0.0075%
Overnight fee time 22:00 (UTC)
Spread 1.8

Oil - Crude

77.44 Price
+3.830% 1D Chg, %
Long position overnight fee -0.0221%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.03

XRP/USD

0.40 Price
+1.040% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 0.00385

BTC/USD

23,277.95 Price
+1.450% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 60.00
video

Still looking for a broker you can trust?

Join the 500.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading